Q3 2019 Investor Presentation

Why invest? driving long-term shareholder value لحا • Market Dynamics Underpenetrated markets in sleep & COPD • Healthcare costs continue to increase • Focus on improving patient outcomes Value-based technology solutions. Growth & Innovation • Global leader in connected health for sleep and respiratory care Long-term growth opportunities 5,500+ patents and designs¹ • ~ 7-8% of revenue invested in R&D Financial Results • Historical revenue and profit growth • Recurring revenue • • Operating excellence program Strong track record of disciplined capital deployment 1. Pending and issued patents and designs as of 3/31/2019 ©2019 ResMed I Q3 2019 Investor Presentation | 5 ResMed

View entire presentation